Quick test for Pseudomonas in lung fluid
Part of Infections clinical trials.
This trial tests a new imaging method to quickly find Pseudomonas aeruginosa bacteria in lung fluid, and then see how well treatment works. It aims to help doctors diagnose and treat this tough infection faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a lung infection with Pseudomonas aeruginosa bacteria confirmed by a test of lung fluid or sputum.
- You are under 90 years old.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to predict how well patients with a ventilator-associated lung infection will respond to treatment. It uses two bronchoscopy samples to track bacteria levels and guide better care.
This study compares a newer, faster lab test (BioFire FilmArray) to standard testing for identifying the germs causing lung infections in hospitalized patients. The goal is to see if the faster test helps doctors choose better antibiotics more quickly.
This trial studies a new testing method (HCAP-Pcr) for people with pneumonia caught in the hospital or other healthcare settings. Doctors will use a special lung washing procedure called bronchoalveolar lavage to quickly identify the cause of the infection, which could help guide treatment faster.
This trial tests a new way to diagnose pneumocystis, a lung infection that can affect people with weakened immune systems. It may help find the infection faster and more accurately using samples taken from your lungs.
This trial uses a rapid test (PCR) to check for bacteria in your lung fluid, so doctors can pick the right antibiotics faster. It's for ICU patients on a breathing machine who may have a lung infection.
This trial tests a quick diagnostic panel to find the exact cause of pneumonia in critically ill patients. It aims to help doctors choose the right antibiotics faster, which may improve recovery.
Hear when a new Pseudomonas Aeruginosa Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.